Copeptina (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Copeptina" in Spanish language version.

refsWebsite

Global rank Spanish rank

9nih.gov

4^th place

9doi.org

2^nd place

1medigraphic.com

low place

928^th place

doi.org

dx.doi.org

Acher R, Chauvet J, Rouille Y (junio de 2002). «Dynamic processing of neuropeptides: sequential conformation shaping of neurohypophysial preprohormones during intraneuronal secretory transport». Journal of Molecular Neuroscience 18 (3): 223-8. PMID 12059040. doi:10.1385/JMN:18:3:223.
Szinnai G, Morgenthaler NG, Berneis K, Struck J, Müller B, Keller U, Christ-Crain M (octubre de 2007). «Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects». The Journal of Clinical Endocrinology and Metabolism 92 (10): 3973-8. PMID 17635944. doi:10.1210/jc.2007-0232.
Katan M, Morgenthaler NG, Dixit KC, Rutishauser J, Brabant GE, Müller B, Christ-Crain M (julio de 2007). «Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay». The Journal of Clinical Endocrinology and Metabolism 92 (7): 2640-3. PMID 17426098. doi:10.1210/jc.2006-2046.
Fenske W, Störk S, Blechschmidt A, Maier SG, Morgenthaler NG, Allolio B (enero de 2009). «Copeptin in the differential diagnosis of hyponatremia». The Journal of Clinical Endocrinology and Metabolism 94 (1): 123-9. PMID 18984663. doi:10.1210/jc.2008-1426.
Khan SQ, Dhillon OS, O'Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL (April 2007). «C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study». Circulation 115 (16): 2103-10. PMID 17420344. doi:10.1161/CIRCULATIONAHA.106.685503.
Reichlin T, Hochholzer W, Stelzig C, Laule K, Freidank H, Morgenthaler NG, Bergmann A, Potocki M, Noveanu M, Breidthardt T, Christ A, Boldanova T, Merki R, Schaub N, Bingisser R, Christ M, Mueller C (June 2009). «Incremental value of copeptin for rapid rule out of acute myocardial infarction». Journal of the American College of Cardiology 54 (1): 60-8. PMID 19555842. doi:10.1016/j.jacc.2009.01.076.
Konstam MA, Gheorghiade M, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C (March 2007). «Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial». JAMA 297 (12): 1319-31. PMID 17384437. doi:10.1001/jama.297.12.1319.
Gheorghiade M, Konstam MA, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C (March 2007). «Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials». JAMA 297 (12): 1332-43. PMID 17384438. doi:10.1001/jama.297.12.1332.
Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R (July 2008). «Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease». Journal of the American College of Cardiology 52 (4): 266-72. PMID 18634981. doi:10.1016/j.jacc.2008.03.050.

medigraphic.com

Copeptina. Un novedoso e interesante biomarcador pronóstico. Autores: Raúl Carrillo-Esper, Teresa de la Torre-León. Med Int Mex 2013; 29:380-387. Consultado el 10 de noviembre de 2019.

nih.gov

ncbi.nlm.nih.gov

Acher R, Chauvet J, Rouille Y (junio de 2002). «Dynamic processing of neuropeptides: sequential conformation shaping of neurohypophysial preprohormones during intraneuronal secretory transport». Journal of Molecular Neuroscience 18 (3): 223-8. PMID 12059040. doi:10.1385/JMN:18:3:223.
Szinnai G, Morgenthaler NG, Berneis K, Struck J, Müller B, Keller U, Christ-Crain M (octubre de 2007). «Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects». The Journal of Clinical Endocrinology and Metabolism 92 (10): 3973-8. PMID 17635944. doi:10.1210/jc.2007-0232.
Katan M, Morgenthaler NG, Dixit KC, Rutishauser J, Brabant GE, Müller B, Christ-Crain M (julio de 2007). «Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay». The Journal of Clinical Endocrinology and Metabolism 92 (7): 2640-3. PMID 17426098. doi:10.1210/jc.2006-2046.
Fenske W, Störk S, Blechschmidt A, Maier SG, Morgenthaler NG, Allolio B (enero de 2009). «Copeptin in the differential diagnosis of hyponatremia». The Journal of Clinical Endocrinology and Metabolism 94 (1): 123-9. PMID 18984663. doi:10.1210/jc.2008-1426.
Khan SQ, Dhillon OS, O'Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL (April 2007). «C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study». Circulation 115 (16): 2103-10. PMID 17420344. doi:10.1161/CIRCULATIONAHA.106.685503.
Reichlin T, Hochholzer W, Stelzig C, Laule K, Freidank H, Morgenthaler NG, Bergmann A, Potocki M, Noveanu M, Breidthardt T, Christ A, Boldanova T, Merki R, Schaub N, Bingisser R, Christ M, Mueller C (June 2009). «Incremental value of copeptin for rapid rule out of acute myocardial infarction». Journal of the American College of Cardiology 54 (1): 60-8. PMID 19555842. doi:10.1016/j.jacc.2009.01.076.
Konstam MA, Gheorghiade M, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C (March 2007). «Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial». JAMA 297 (12): 1319-31. PMID 17384437. doi:10.1001/jama.297.12.1319.
Gheorghiade M, Konstam MA, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C (March 2007). «Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials». JAMA 297 (12): 1332-43. PMID 17384438. doi:10.1001/jama.297.12.1332.
Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R (July 2008). «Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease». Journal of the American College of Cardiology 52 (4): 266-72. PMID 18634981. doi:10.1016/j.jacc.2008.03.050.